গাইড লিঙ্ক ক্যুইজ · মাঝারি স্তর

AI in Prostate Cancer MRI Quiz

Tests AI support for prostate MRI, PI-RADS context, study generalizability, clinical review, and patient-centered follow-up.

সম্পর্কিত গাইড পাথAI In Prostate Cancer Mri
প্রশ্ন 1 এর 8

What can AI contribute to prostate MRI interpretation?

প্রতিটি প্রশ্নের পূর্বরূপ দেখুন8 প্রশ্ন

আপনি কুইজ নেওয়ার সাথে সাথে উত্তর এবং ব্যাখ্যাগুলি উপস্থিত হয়।

  1. What can AI contribute to prostate MRI interpretation?
    • Confirm cancer without pathology or clinical context
    • Choose a biopsy treatment plan automatically
    • Replace all MRI sequences with one image score
    • Localize candidate lesions or support risk assessment for clinician review
  2. What does PI-RADS provide in prostate MRI?
    • A guarantee that a detected lesion is malignant
    • A laboratory quality-control requirement
    • A structured framework radiologists use to describe and assess findings
    • A genetic variant classification standard
  3. Why is prospective validation useful after a promising MRI AI study?
    • It guarantees improved patient outcomes
    • It tests whether performance transfers to real clinical workflows and populations
    • It proves the model will work on every scanner
    • It removes the need for a reference standard
  4. Which evidence should be used to evaluate prostate MRI AI?
    • Pathology or well-defined follow-up, with relevant sensitivity and specificity measures
    • শুধুমাত্র মডেলের প্রশিক্ষণ ক্ষতি
    • The number of highlighted pixels
    • The clinician’s preferred image viewer
  5. Why can a retrospective enriched test set overstate performance?
    • It has too many MRI sequences to interpret
    • Pathology cannot be used as a reference
    • It automatically represents every clinic
    • Its patient mix may differ from the population and prevalence where the tool will be used
  6. How should a patient interpret an AI-highlighted prostate lesion?
    • As a treatment recommendation from the model
    • As a finding for radiologist and clinician assessment, not a diagnosis
    • As proof that cancer is present
    • As proof that biopsy is unnecessary
  7. What information should accompany a prostate MRI AI audit?
    • Scanner and sequence protocol, software version, reader interaction, and follow-up outcomes
    • Only the radiologist’s initials
    • The model’s color palette
    • The patient’s unrelated billing history
  8. Which decision belongs in shared clinical decision-making?
    • The scan score overriding patient preference
    • A software update setting the biopsy threshold without review
    • Whether AI findings, PSA, history, and other evidence support biopsy or follow-up
    • The model alone deciding treatment